Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB-IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy.
Kinjo Y, Matsuura Y, Ohguri T, Aoyama Y, Murakami M, Hoshino K, Harada H, Ueda T, Kurita T, Kagami S, Yoshino K. Kinjo Y, et al. Among authors: aoyama y. Mol Clin Oncol. 2022 Jun;16(6):105. doi: 10.3892/mco.2022.2538. Epub 2022 Apr 19. Mol Clin Oncol. 2022. PMID: 35620209 Free PMC article.
Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages.
Aoyama Y, Yamazaki H, Nishimua K, Nomura M, Shigehiro T, Suzuki T, Zang W, Tatara Y, Ito H, Hayashi Y, Koike Y, Fukumoto M, Tanaka A, Zhang Y, Saika W, Hasegawa C, Kasai S, Kong Y, Minakuchi Y, Itoh K Professor, Yamamoto M, Toyokuni S, Toyoda A, Ikawa T, Takaori-Kondo A, Inoue D. Aoyama Y, et al. Blood. 2025 Jan 7:blood.2024025402. doi: 10.1182/blood.2024025402. Online ahead of print. Blood. 2025. PMID: 39775457
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Aoyama Y, Ozaki Y, Kizawa R, Masuda J, Kawai S, Kurata M, Maeda T, Yoshida K, Yamashita N, Nishimura M, Hosonaga M, Fukada I, Hara F, Kobayashi T, Takano T, Ueno T. Aoyama Y, et al. Breast Cancer. 2024 Dec 7. doi: 10.1007/s12282-024-01657-4. Online ahead of print. Breast Cancer. 2024. PMID: 39644440
990 results